Clinical Trial Update: RCT of CBD for Anxiety in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated cannabidiol (CBD) for anxiety symptoms in patients with advanced breast cancer, with trial results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Breast Cancer

Drugs mentioned

• CBD (cannabidiol)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Advanced Breast Cancer, Anxiety | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-29